about
Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriersLeft ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinantsAssociation of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.Low gradient severe aortic stenosis with preserved ejection fraction: reclassification of severity by fusion of Doppler and computed tomographic data.Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure).Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair.Usefulness of echocardiographic assessment of cardiac and ascending aorta calcific deposits to predict coronary artery calcium and presence and severity of obstructive coronary artery disease.Real-time three-dimensional echocardiography as a novel approach to quantify left ventricular dyssynchrony: a comparison study with phase analysis of gated myocardial perfusion single photon emission computed tomographyCardiac Resynchronization Therapy in CKD Stage 4 PatientsLeft ventricular dyssynchrony assessed by two three-dimensional imaging modalities: phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging.Effect of statins on aortic root growth rate in patients with bicuspid aortic valve anatomy.A prediction model for progressive disease in systemic sclerosisImpact of age on transcatheter aortic valve implantation outcomes: a comparison of patients aged ≤ 80 years versus patients > 80 years.Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis.Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapyNuclear imaging in cardiac resynchronization therapy.Noninvasive imaging in cardiac resynchronization therapy--part 1: selection of patients.Predicting response to CRT. The value of two- and three-dimensional echocardiography.Noninvasive imaging in cardiac resynchronization therapy--Part 2: Follow-up and optimization of settings.Real-time three dimensional echocardiography: current and future clinical applications.QRS duration versus morphology and survival after cardiac resynchronization therapy.Role of left ventricular twist mechanics in the assessment of cardiac dyssynchrony in heart failure.Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility.Multimodality imaging before, during, and after percutaneous mitral valve repair.Contemporary imaging of normal mitral valve anatomy and function.Advanced techniques in dobutamine stress echocardiography: focus on myocardial deformation analysis.Cardiac resynchronisation therapy in populations underrepresented in randomised controlled trials.Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation.Transcatheter mitral valve repair therapies for primary and secondary mitral regurgitation.The role of multimodality imaging in the selection of patients for aortic valve repair.Prognostic implications of descending thoracic aorta dilation after surgery for aortic dissection.Mechanical dyssynchrony in patients with heart failure and reduced ejection fraction: how to measure?Sex Differences in Phenotypes of Bicuspid Aortic Valve and Aortopathy: Insights From a Large Multicenter, International Registry.Myocardial strain to detect subtle left ventricular systolic dysfunction.Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in patients undergoing transcatheter aortic valve implantation.Prognostic Implications of Raphe in Bicuspid Aortic Valve Anatomy.Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis.Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.Time course, predictors, and prognostic implications of significant mitral regurgitation after ST-segment elevation myocardial infarction.
P50
Q28730121-B141E57D-AB19-41C4-BBC9-AE72A309E464Q30467327-A47363F4-234E-4D2C-82B9-CA605F33876DQ30478105-B0992205-3712-4232-87A8-8BD92A3EB060Q30963372-7CD72431-7531-464B-BCA9-036719E6617DQ33507493-8FE5DE10-B478-4007-BF36-0B661B25DADFQ34338521-BCB6CE90-EDD1-47BD-A447-9BC49951E06EQ34606423-3691DE1E-69F2-4803-8CCA-C1563BB2715AQ34620977-12827185-FE31-42F8-97CC-85E05D25C068Q36123579-83DB69E6-27D4-4F15-80D7-2A7169D2E6BBQ36237806-650F9AEC-17C8-4AF4-A730-0B634B42C430Q36297330-08155250-D38D-4256-8E6F-2059B81006FCQ36375900-267A1594-E5E6-4537-B1C2-B4B6A1EB060FQ36578428-F482781D-393F-41E7-B1AC-539A9331AB0EQ36709262-1CDFE0BC-19DF-4640-AA75-B42EABFF2866Q36720290-A8EE64EB-FA68-4998-8811-C3770CC41CDEQ37023108-FF07122E-D3C2-4A24-B0E9-2B28E7A9E876Q37307892-7F50C749-73A6-4D27-90AD-1C0D812C1B96Q37309981-D0EB5241-90BF-4678-9863-BE68540952BBQ37344956-18166C7D-104F-4BFD-BA34-86E58456DDFDQ37624208-C3A8669B-BD84-4490-B6D6-5C7A3F9FD10CQ37625580-A4E9E52D-94E1-4D53-919D-4B6C4A8D2EC3Q37677211-36152BC0-0590-41B2-9EBE-0FDFDDA84AFCQ37778676-28F7173C-2C2D-466B-BDB5-19C984D17274Q37806441-F11CD23F-781D-4F44-A72F-8F95402D2ECEQ37939083-E8D03B39-27BC-4E0B-AD8A-367A22953B4AQ38028247-7645657D-5D92-4A20-9013-1400F44A6B2DQ38206758-658AB7F6-DC9F-48A5-919F-0AC93DF66120Q38210973-A61BE5EF-3A10-496D-B57D-66DC62E3FFD8Q38269963-1AC10417-855D-45A0-AC59-06352738F5C0Q38373846-35B06972-E480-47B8-A80C-1963FC783DCDQ38625198-28ED1A70-ED7E-40BE-8CB3-18B4C184E8EEQ38798294-F6CB19D9-D9B0-44D8-A8CC-011F34177E28Q38870643-2BD37D00-C054-4B37-ADC5-94F1895C1593Q38934018-A0B8A6AC-13A7-4B52-AD87-A3E2E0D085D6Q39021835-14B7CD39-5AEB-43BE-9A0B-BB6876B108F4Q39026260-531863DB-30FE-48FA-A139-5347B806EEE3Q39041102-91F8306D-18C5-406B-A82E-2D8B049D03F1Q39093286-FA7FED08-D627-41DD-9CC7-35C5544149FAQ39111684-BEDD9E54-867E-4096-8B13-C865FD0A1BD9Q39510688-5A06F931-352B-4E88-AD9A-2949ECBA77DE
P50
name
Nina Ajmone Marsan
@en
Nina Ajmone Marsan
@nl
type
label
Nina Ajmone Marsan
@en
Nina Ajmone Marsan
@nl
prefLabel
Nina Ajmone Marsan
@en
Nina Ajmone Marsan
@nl